Synbio International Signs Exclusive Licensing Agreement for Proprietary Nutraceutical Products, Accelerating Path to Revenue
Partnership with MD PHD Wellness Establishes a Long-Term Product Pipeline; Flagship Formulation to Be Marketed Under Synbio’s Healing Force™ Brand NEW YORK, NY – TheNewswire - Sept. 8, 2026 – Synbio International, Inc. (OTC: SYIN) today announced it has entered into a Strategic Licensing, Manufacturing, Supply and Revenue Sharing Agreement with MD PHD Wellness, Inc., securing the exclusive rights to commercialize MD PHD Wellness’ proprietary nutraceutical formulations throughout the United States and Canada. The agreement covers MD PHD Wellness’ flagship anti-anxiety nutraceutical formulation, to be marketed under Synbio’s Healing Force™ brand, and establishes a framework for the parties to evaluate and commercialize additional proprietary wellness products over time. Importantly, it provides Synbio with immediate access to proprietary nutraceutical products without the time and cost burden of developing formulations from scratch, significantly accelerating the Company’s path to revenue generation. Under the agreement, MD PHD Wellness will oversee product development, manufacturing, quality assurance, and supply chain management, while Synbio will be responsible for branding, marke
Free plan · Plus CA$29 or Pro CA$99/month
